Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > September/October 2013 - Volume 20 - Issue 5 > [kappa]-opioid Receptor Activation Prevents Against Arrhythm...
American Journal of Therapeutics:
doi: 10.1097/MJT.0b013e3182456676
Original Article

[kappa]-opioid Receptor Activation Prevents Against Arrhythmias by Preserving Cx43 Protein Via Alleviation of Intracellular Calcium

Shi, Quan-Xing PhD1; Zhang, Li-Jun PhD1; Yao, Yuan PhD1; Zhang, Quan-Yu PhD2; Wang, Wei MS1; Li, Juan PhD1; Shang, Yu-Long PhD1; Bi, Hui PhD1; Zhang, Shu-Miao PhD1; Guo, Hai-Tao PhD1; Wang, Yue-Min PhD1; Yu, Shi-Qiang PhD3; Yi, Ding-Hua PhD3; Bueno, Franklin Rivera MS4; Kaye, Alan David MD, PhD4,5,*; Pei, Jian-Ming PhD1,*

Collapse Box

Abstract

κ-opioid receptor (κ-OR) activation with U50,488H, a selective κ-OR agonist, has been previously demonstrated to prevent against cardiac arrhythmias via stabilizing the synthesis and degradation of an integral membrane protein, Cx43, in gap junctions. However, the exact prevention mechanism remains unclear. The present study tested the hypothesis that the kappa OR agonist U50,488H mediates the prevention of arrhythmia through the regulation of intracellular calcium leading to the preservation of Cx43 protein. By performing electrocardiogram monitoring and immunoblotting in isolated Langendorff-perfused rat hearts, high concentrations of calcium-perfused rat hearts exhibited increased cardiac arrhythmias. Diminished expression of Cx43 protein was observed. The utilization of a whole-cell patch clamp technique revealed that U50,488H inhibited L-type calcium current in single ventricular myocytes in a dose-dependent manner. These effects were blocked by nor-binaltorphimine, potent and selective κ-OR antagonists. Administration of U50,488H before myocardial ischemia resulted in an attenuated of total arrhythmia scores. The attenuation effect was blocked by nor-binaltorphimine. The attenuation effect was antagonized both by Bay K8644, a L-type calcium channel agonist, and also by the Cx43 uncoupler heptanol. Finally, immunoblotting data demonstrated that the preservation of Cx43 protein conferred by U50,488H was reversed in the presence of Bay K8644. In summary, the present study demonstrates κ-OR activation with U50,488H may confer antiarrhythmic effects via modulation of the calcium-Cx43 pathway.

Copyright © 2012 by Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.